Survival analysis revealed that GPR55 overexpression predicted much better survival outcomes in HCC patients, and we think that the better prognosis of GPR55 in HCC could be partly attributed to the immune microenvironment in HCC tissues. This evidence concerns the gene GPR55 and hepatocellular carcinoma.